Skip to main content
OpenTrials
Completed

NCT Number: NCT06842888

Comparing Mirror Therapy Rehabilitation Device to Conventional Mirror Therapy

This is a randomized controlled trial which will compare conventional mirror therapy with mirror therapy using the Miraπ device which physically moves a patient's affected limb.

This study will use two parallel groups: (1) receiving conventional mirror therapy as a part of the standard of care as conducted by the participant's clinical care team and (2) receiving mirror therapy with the Miraπ device as conducted by study personnel with the oversight of the participant's clinical care team.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Impaired Motor Function Nervous System Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rehabilitation and Wellness Center at the Milford Campus of Bridgeport Hospital

Milford, Connecticut, 06460, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants currently accepted and cleared for rehabilitation in the inpatient rehabilitation unit by the rehabilitation medical director.
  • Participants with paralysis or motor function problems of only one hand.
  • Participants need mirror therapy because of their health condition.
  • Participants' rehabilitation physician determined that mirror therapy would be appropriate for standard of care.
  • Participants are able to memorize easy tasks, and able to follow instructions e.g., moving the healthy fingers.

Exclusion criteria

  • Participants who are not cleared physically or medically to participate in standard acute inpatient rehabilitation therapies by the rehabilitation medical director
  • Participants who are not able to memorize easy tasks, e.g., moving the healthy fingers.
  • Participants with spasticity of the affected hand (as assed by the occupational therapist)
  • Minors
  • Vulnerable populations

Treatment and study plan

Miraπ

Device

This device has tiny sensors that measure the movement of the healthy fingers and tiny motors that move the affected fingers of the patient.

The device is connected to a specially designed finger mechanism that moves the affected fingers of the patient. This opening mechanism is designed in a way that it prevents the fingers from being forced into any hurting position. If the patient moves the healthy fingers during training, also the fingers of the affected hand are moved by the device at the same time. This creates the effect of mirror therapy for the brain as the patient can see both hands moving.

Mirror Therapy

Behavioral

Current standard of care using MT.

Primary outcomes

  1. Change in Jebsen-Taylor Hand Function Test score

    Time frame: At baseline and at discharge (approximately 2-3 weeks after baseline)

    Percentage score, which determines how well a participant can do motor tasks for range of motion, strength, and tasks of activities of daily life. Participants have up to 120 seconds to complete tasks. Lower scores indicate less impairment.

  2. McGill Pain Questionnaire (MPQ)

    Time frame: At baseline and at discharge (approximately 2-3 weeks after baseline)

    The MPQ is scored by summing the values of words that best describe a person's pain. The score ranges from 0 (no pain) to 78 (severe pain)

  3. Change in Visual Analog Scale (VAS) to assess Pain

    Time frame: At baseline and at discharge (approximately 2-3 weeks after baseline)

    The VAS pain scale is a tool for assessing pain intensity. Participants will be asked to mark a point on a 100 mm horizontal line that represents the intensity of their pain. This line has two endpoints: 0: No pain and 100: Worst possible pain imaginable. The distance from the "0" to the mark is measured in millimeters with the resulting number (0-100) being the VAS pain score

Sponsors and collaborators

Lead sponsor

Yale University

Other

Registry information

Acronym: MiraPi

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Feb 24, 2025
Registry last updated
Dec 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.